Skip to Main Content
Skip Nav Destination

Issues

Acta Haematologica 2021, Vol. 144, No. 5

Editorial Comment

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (5): 473–475. https://doi.org/10.1159/000515758

Systematic Review

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (5): 476–483. https://doi.org/10.1159/000515104

Review

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (5): 484–499. https://doi.org/10.1159/000512929
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (5): 500–507. https://doi.org/10.1159/000513036
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (5): 508–518. https://doi.org/10.1159/000514071

Original Paper

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (5): 519–527. https://doi.org/10.1159/000512165
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (5): 528–533. https://doi.org/10.1159/000511698
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (5): 534–541. https://doi.org/10.1159/000513696
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (5): 542–550. https://doi.org/10.1159/000514671
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (5): 551–559. https://doi.org/10.1159/000514907
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (5): 560–568. https://doi.org/10.1159/000514920
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (5): 569–579. https://doi.org/10.1159/000507973

Brief Communication

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (5): 580–584. https://doi.org/10.1159/000515258

Case Report

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (5): 585–590. https://doi.org/10.1159/000513925

PharmaForum

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (5): 592–593. https://doi.org/10.1159/000518592
Close Modal

or Create an Account

Close Modal
Close Modal